Shuttle Pharmaceuticals Holdings (SHPH) Cash from Operations (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Cash from Operations history runs 6 years deep, the most recent figure standing at 2417309.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 4.34% year-over-year to 2417309.0 in Q1 2026; TTM through Mar 2026 was 9372030.0, a 8.79% decrease from a year earlier, with the FY2025 full-year figure at 9481645.0, down 29.4% from the prior year.
• Cash from Operations retreated to 2417309.0 in Q1 2026 per SHPH's latest filing, from 973012.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 355420.0 in Q2 2022 and bottomed at 3355055.0 in Q2 2025.
• The 5-year median for Cash from Operations is 1399342.0 (2024), against an average of 1616102.47.
• Across the five-year window, Cash from Operations plunged 370.45% in 2022 and surged 63.83% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 635824.0 in 2022, then slumped by 67.05% to 1062174.0 in 2023, then sank by 153.27% to 2690162.0 in 2024, then jumped by 63.83% to 973012.0 in 2025, then slumped by 148.44% to 2417309.0 in 2026.
• Per Business Quant, the three latest SHPH Cash from Operations figures stand at 2417309.0 (Q1 2026), 973012.0 (Q4 2025), and 2626654.0 (Q3 2025).